Israeli pill shows promise for diabetes

TEL AVIV, Israel — Oramed Pharmaceuticals, the Israeli drugmaker seeking to develop the first oral pill for diabetes, said a trial on type 2 diabetes patients showed that the medicine has promising therapeutic potential.

The one-week study of 30 patients also met safety goals, the Jerusalem-based company said Thursday. Oramed plans to follow the mid-stage trial with another study later this year.

“The results we announced today give us confidence about the chances of success in a bigger trial going forward,” Chief Executive Officer Nadav Kidron said at a press conference Thursday at the Tel Aviv Stock Exchange. “We are also excited about the potential of this drug for type 1 diabetes.”

The results bring Oramed, whose stock has more than tripled in the past year, a step closer to doing something no company has ever done: develop oral insulin. The technology has eluded scientists for decades and Novo Nordisk, a Danish developer of diabetes products valued at about $104 billion, has yet to develop a pill to replace daily shots.

While Oramed is years away from a potential approval, it’s taking advantage of the growing attention to raise money. The company raised $16 million on Dec. 25, five days after it said it had successful results in an early-stage type 1 diabetes study. On Jan. 24, the company filed to raise as much as $100 million.

The market for drugs to treat diabetes is likely to grow to more than $58 billion in 2018 from $35 billion in 2012, Standard &Poor’s wrote in an October report.

Diabetes afflicted 371 million people and killed 4.8 million worldwide in 2012, according to the International Diabetes Federation. People with type 2 diabetes don’t produce enough insulin, a hormone that helps the body use or store blood sugar, or can’t use the insulin properly. The illness, the most common form of diabetes, often strikes people over the age of 40, and is tied to obesity and sedentary lifestyles.

The drugmaker’s Protein Oral Delivery, or POD, technology, is based on research by scientists at Jerusalem’s Hadassah Medical Center.

The Phase IIa trial detailed Thursday will be followed by a Phase IIb study.

Talk to us

More in Local News

Mt. Baker visible from the summit of Mt. Dickerman on a late summer day in 2017. (Caleb Hutton / The Herald)
Hornets pester hikers on popular Mountain Loop trails

“You cannot out run the stings,” one hiker wrote in a trip report. The Forest Service has posted alerts at two trailheads.

A view of a 6 parcel, 4.4 acre piece of land in Edmonds, south of Edmonds-Woodway High School on Wednesday, Sept. 20, 2023 in Edmonds, Washington. (Olivia Vanni / The Herald)
Housing authority seeks more property in Edmonds

The Housing Authority of Snohomish County doesn’t have specific plans for land near 80th Avenue West, if its offer is accepted.

Nursing Administration Supervisor Susan Williams points at a list of current COVID patients at Providence Regional Medical Center on Friday, Sept. 22, 2023 in Everett, Washington. (Olivia Vanni / The Herald)
Dozens of Providence patients in medical limbo for months, even years

About 100 people are stuck in Everett hospital beds without an urgent medical reason. New laws aim for a solution.

Emergency responders surround an ultralight airplane that crashed Friday, Sept. 22, 2023, at the Arlington Municipal Airport in Arlington, Washington, resulting in the pilot's death. (Ryan Berry / The Herald)
Pilot dead in ultralight plane crash at Arlington Municipal Airport

There were no other injuries or fatalities reported, a city spokesperson said.

Cash is used for a purchase at Molly Moon's Ice Cream in Edmonds, Washington on Wednesday, Aug. 30, 2023. (Annie Barker / The Herald)
County Council delays vote on requiring businesses to take cash

Concerns over information and enforcement postponed the council’s scheduled vote on the ordinance Wednesday in Snohomish County.

A girl walks her dog along a path lined with dandelions at Willis D. Tucker Community Park on Monday, Sept. 11, 2023, in Snohomish, Washington. (Olivia Vanni / The Herald)
Spraying in Willis Tucker Park resurfaces debate over herbicides

Park staff treated about 11,000 square feet with glyphosate and 2,4-D. When applied correctly, staff said they aren’t harmful.

One of Snohomish County PUD’s new smart readers is installed at a single family home Thursday, Sept. 21, 2023, in Mill Creek, Washington. (Ryan Berry / The Herald)
PUD program seeks to make energy grid smarter for 380K customers

The public utility’s ConnectUp program will update 380,000 electric meters and 23,000 water meters in the next few years.

An example of the Malicious Women Co. products (left) vs. the Malicious Mermaid's products (right). (U.S. District Court in Florida)
Judge: Cheeky candle copycat must pay Snohomish company over $800K

The owner of the Malicious Women Co. doesn’t expect to receive any money from the Malicious Mermaid, a Florida-based copycat.

A grave marker for Blaze the horse. (Photo provided)
After Darrington woman’s horse died, she didn’t know what to do

Sidney Montooth boarded her horse Blaze. When he died, she was “a wreck” — and at a loss as to what to do with his remains.

Most Read